Patient self-monitoring after melanoma excision 'has potential'

A pilot study suggests that compared with clinician-led care, self-examination may lead to more timely detection of new malignant lesions

Allowing patients who have had a localised primary melanoma excision to carry out self-surveillance may be a promising new model of follow-up care, Australian dermatologists say.

Their pilot randomised controlled trial of patient-led surveillance in 100 people over six months found such monitoring was safe, feasible and as acceptable to patients as doctor-led care.

The participants (mean age 59, 54% men) were undergoing routine follow-up at one of two melanoma specialty clinics in Sydney